Gupta Ankur, Nagaraju Shankar Prasad, Bhojaraja Mohan V, Swaminathan Shilna Muttickal, Mohan Pooja Basthi
From the Department of Medicine, Whakatane Hospital, Whakatane, New Zealand.
the Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
South Med J. 2023 Feb;116(2):237-244. doi: 10.14423/SMJ.0000000000001516.
Hypertension (HTN) and chronic kidney disease (CKD) are pathophysiologic states that are intimately related, such that long-term HTN can lead to poor kidney function, and renal function decline can lead to worsening blood pressure (BP) control. HTN in CKD is caused by an interplay of factors, including salt and water retention, with extracellular volume expansion, sympathetic nervous system overactivity, renin-angiotensin-aldosterone system activation, and endothelial dysfunction. BP variability in the CKD population is significant, however, and thus requires close monitoring for appropriate management. With accumulating evidence, the diagnosis as well as management of HTN in CKD has been evolving in the last decade. In this comprehensive review based on current evidence and recommendations, we summarize the basics of pathophysiology, BP variability, diagnosis, and management of HTN in CKD with an emphasis on special populations with CKD.
高血压(HTN)和慢性肾脏病(CKD)是密切相关的病理生理状态,长期高血压可导致肾功能不佳,而肾功能下降会导致血压(BP)控制恶化。CKD中的高血压是由多种因素相互作用引起的,包括钠水潴留、细胞外液量增加、交感神经系统过度活跃、肾素-血管紧张素-醛固酮系统激活以及内皮功能障碍。然而,CKD人群的血压变异性很大,因此需要密切监测以进行适当管理。随着证据的积累,过去十年中CKD患者高血压的诊断和管理一直在不断发展。在基于当前证据和建议的这篇全面综述中,我们总结了CKD中高血压的病理生理学、血压变异性、诊断和管理的基础知识,重点关注患有CKD的特殊人群。